Apoptosis-inducing vanadium complexes

Drugs of the Future

Volumn 25, Issue 10, 2000, Pages 1053-1068

  Narla, R K ^a   Dong, Y ^a   Ghosh, P ^a   Thoen, K ^a   Uckun, F M ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 2,2' BIPYRIDINE DERIVATIVE; 2,21 BIPYRIMIDYL DERIVATIVE; BIPYRIDINE DERIVATIVE; CISPLATIN; FREE RADICAL; HAFNIUM; LIGAND; METAL COMPLEX; MOLYBDENUM; PLATINUM DERIVATIVE; TITANOCENE; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE; VANADOCENE; ZIRCONOCENE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL VIABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; REVIEW;

EID: 0033638988     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2000.025.10.858697     Document Type: Review

References (77)

1. Vanadium pentoxide dust: A clinical and experimental investigation on its effect after inhalation
2. The chemistry of peroxovanadium compounds relevant to insulin mimesis
3. Vanadium in mammalian physiology and nutrition
4. From Vanadis to Atropos: Vanadium compounds as pharmacological tools in cell death signalling
5. Effects of vanadium on glucose metabolism in vitro
6. +)ATPase inhibitor
7. Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl(IV) ions
8. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats
9. Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum(ll) and metallocene dichlorides
10. 2 after treatment of Ehrlich ascites tumor cells with metallocene dichlorides and cis-platinum in vitro
11. Tumor inhibition by metallocenes: Ultrastructural localization of titanium and vanadium in treated tumor cells by electron energy loss spectroscopy
12. Complexes of metals other than platinum as antitumouragents
13. Tumor inhibition by metallocenes: Activity against leukemias and detection of the systemic effect
14. Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium
15. Vanadium
16. Trace elements: Potential importance in human nutrition with particular reference to zinc and vanadium
17. Glutathione reduces cytoplasmic vanadate: Mechanism and physiological implications
18. Vanadium, an indispensable trace element in living organisms: Current data on biochemical, metabolic levels and therapeutic doses
19. The essential trace elements
20. Role of trace elements in cancer
21. Vanadium
22. Mechanisms of action of vanadium
23. Oxidative stress of vanadium-mediated oxygen free radical generation stimulated by aluminum on human erythrocytes
24. Vanadium(IV)-mediated free radical generation and related 2-deoxyguanosine hydroxylation and DNA damage
25. Antitumor activities of vanadium(IV), manganese(IV), iron(III), cobalt(II) and copper(II) complexes of 2methylaminopyridine
26. Vanadium-mediated lipid peroxidation in microsomes from human term placenta
27. Vanadium compounds: Biological actions and potential as pharmacological agents
28. Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors: Redox independent activation of NF-κB
29. Molecular genotoxicity profiles of apoptosis-inducing vanadocene complexes
30. Peroxovanadium compounds: Biological actions and mechanism of insulin-mimesis
31. Increased potency of vanadium using organic ligands
32. Antitumor activity of vanadium compounds
33. Lineage-specific induction of B cell apoptosis and altered signal transduction by the phosphotyrosine phosphatase inhibitor bis(maltolato)oxovanadium(IV)
34. 2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: Studies on a neuronal and a glial cell line
35. Mechanism for a new antitumor vanadium complex: Hydroxyl radical-dependent DNA cleavage by 1, 10-phenanthroline-vanadyl complex in the presence of hydrogen peroxide
36. Aqueous coordination chemistry of vanadocene dichloride with nucleotides and phosphoesters: Mechanistic implications for new class of antitumor agents
37. 2-type complex
38. Apoptosis-inducing vanadocene compounds against human testicular cancer
39. Bis(4, 7-dimethyl- 1, 10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent
40. Synthesis, X-ray structure, and antileukemic activity of oxovanadium(IV) complexes
41. Bis-cyclopentadienyl compounds of Ti, Zr, V, Nb, and Ta
42. Pseudohallde and chelate complexes of bis(cyclopentadienyl)vanadium(IV)
43. 2Y]
44. A chlorotitanocene tetrachloroferate complex stabilized by acetonitrile coordination
45. 2
46. Dithiochelates of the bis(p-cyclopentadienyl)vanadium(IV) moiety. II. N,N-Dialkyldithiocarbamate and O, O'-dialkyldithiophosphate complex
47. Spermicidal activity of chelated complexes of bis(cyclopentadienyl)vanadium(IV)
48. Synthesis and characterization of halogen and pseudohalogen derivatives of substituted vanadocenes
49. 2
50. 4-(3-Bromo-4-hydroxylphenyl)amino-6, 7-dimethoxyquinazoline: A novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells
51. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
52. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
53. Calphostin C triggers calcium-dependent apoptosis in human acute lymphoblastic leukemia cells
54. Tumor inhibition by titanocene complexes: Activity against B 16 melanoma and colon 38 carcinoma
55. Titanocene dichloride - The first metallocene with cancerostatic activity
56. Tumor inhibition by titanocene dichloride: First clues to the mechanism of action
57. Antitumor activity of titanocene dichloride in xenografted human renal cell carcinoma
58. Tumor inhibition by titanocene complexes: Influence upon two xenografted human lung carcinomas
59. Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives
60. 2Ti or DNA-CpTi adducts depending on pH
61. Peroxo heteroligand vanadates(V): Synthesis, spectra-structure relationships, and stability toward decomposition
62. Interleukin-7 receptor ligation stimulates tyrosine phosphorylation, inositol phospholipid turnover, and clonal proliferation of human B-cell precursors
63. Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia
64. Metal complexes as enzyme inhibitors
65. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans
66. Plasmid DNA cleavage by oxo-bridged vanadium(III) dimers without added co-oxidants or reductants
67. Use of chelation agents to inhibit enzymes
68. Activation of p53 transcriptional activity by 1, 10-phenanthroline, a metal chelator and redox sensitive compound
69. P53, cell cycle control and apoptosis: Implications for cancer
70. Molecular controls of growth arrest and apoptosis: p53-Dependent and independent pathways
71. Cisplatin and its analogues
72. Intracellular distribution of titanium after treatment with the antitumor agent titanocene dichloride.' On electron energy loss spectroscopic study
73. Organometallic anticancer agents: The effect of the central metal and halide ligands on the interaction of metallocene dihalides Cp2MX2 with nucleic acid constituents
74. Intracellular localization of titanium within xenografted sensitive human tumors after treatment with the antitumor agent titanocene dichloride
75. Structural and functional characterization of seven spermicidal vanadium complexes: Potentiation of activity by methyl substitution on the cyclopentadienyl rings